Golimumab

🧮 Dose calculator

Rheumatoid arthritis · Regimen source: FDA Simponi · 2.2

• • Before starting: screen for active and latent TB (treat latent TB first) and complete age-appropriate vaccines. FDA Simponi · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Simponi · 8.1

  “Risk Summary Available data from postmarketing case reports with golimumab use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Simponi · 8.2

  “Risk Summary There is no information regarding the presence of SIMPONI in human milk, the effects on breastfed infants, or the effects on milk production.”

• 👶 ChildrenUse with caution

  Label: established for ulcerative colitis in children ≥15 kg; boxed warning of lymphoma and malignancy in children and adolescents. FDA Simponi · 8.4

  “The safety and effectiveness of SIMPONI for the treatment of moderately to severely active ulcerative colitis have been established in pediatric patients weighing at least 15 kg.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Simponi · 8.5

  “Because there is a higher incidence of infections in the geriatric population in general, caution should be used in treating geriatric patients with SIMPONI [see Warnings and Precautions (5.1 , 5.5) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.